amrytpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://amrytpharma.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Amryt Pharma - Hope for those with the greatest |
| Description | Our vision is to be a leading global rare disease company by acquiring, developing and We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 31.170.121.169 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
amrytpharma.com Valuation
|
US$17,233,227
Last updated: 2023-04-28 09:08:03
amrytpharma.com has Semrush global rank of 614,180. amrytpharma.com has an estimated worth of US$ 17,233,227, based on its estimated Ads revenue. amrytpharma.com receives approximately 1,988,450 unique visitors each day. Its web server is located in United Kingdom, with IP address 31.170.121.169. According to SiteAdvisor, amrytpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$17,233,227 |
| Daily Ads Revenue | US$15,908 |
| Monthly Ads Revenue | US$477,228 |
| Yearly Ads Revenue | US$5,726,734 |
| Daily Unique Visitors | 132,564 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| amrytpharma.com. | A | 3598 | IP: 31.170.121.169 |
| amrytpharma.com. | NS | 3600 | NS Record: ns4.blacknight.com. |
| amrytpharma.com. | NS | 3600 | NS Record: ns3.blacknight.com. |
| amrytpharma.com. | NS | 3600 | NS Record: ns1.blacknight.com. |
| amrytpharma.com. | NS | 3600 | NS Record: ns2.blacknight.com. |
| amrytpharma.com. | MX | 3600 | MX Record: 10 eu-smtp-inbound-2.mimecast.com. |
| amrytpharma.com. | MX | 3600 | MX Record: 10 eu-smtp-inbound-1.mimecast.com. |
| amrytpharma.com. | TXT | 3600 | TXT Record: google-site-verification=CKqq1LciR0v4QWzRKXf7X6jXBTAE7lLSCOhv5cNgXQY |
| amrytpharma.com. | TXT | 3600 | TXT Record: e9a1oc7hngqb3hu1lbobvfhvpi |
| amrytpharma.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=a5003994938a52cc593a5765bcc5be4a3ff715159ecdcad7ca5f0ef550a078fd |
| amrytpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:eu._netblocks.mimecast.com include:us._netblocks.mimecast.com include:amazonses.com include:spf.servicemail24.de ip4:167.89.71.136 ip4:103.2.142.50 -all |
| amrytpharma.com. | TXT | 3600 | TXT Record: 0ed1fe018a2a33774526fd4b31ba736a6465c8edce |
| amrytpharma.com. | TXT | 3600 | TXT Record: h9vqm31cd8m9akoh1uqd9ams6a |
| amrytpharma.com. | TXT | 3600 | TXT Record: MS=ms45314685 |
| amrytpharma.com. | TXT | 3600 | TXT Record: 3844jl36imuhsaugco066a3tla |
HtmlToTextCheckTime:2023-04-28 09:08:03
| About us About us Our team Join us Contact us Corporate social responsibility Code of conduct Amryt compliance Aegerion Consent Decree Patients and carers Patients and carers Homozygous familial hypercholesterolaemia Lipodystrophy Epidermolysis bullosa Acromegaly Advocacy Healthcare professionals Healthcare professionals Our science Trials and registries Expanded access programme Medical information enquiries Grants and donations Research study requests Product portfolio Product portfolio Juxtapid ® / Lojuxta ® ▼ Myalept ® / Myalepta ® ▼ Mycapssa ® Pipeline Report adverse event Newsroom Investors The Company News Reports and presentations Stock information Events Corporate governance AIM Delisting Contingent Value Rights (CVR) FAQ Analysts Contacts and advisors Business development About us About us Our team Join us Contact us Corporate social responsibility Code of conduct Amryt compliance Aegerion Consent Decree Patients and carers Patients and carers Homozygous familial |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 11:55:18 GMT Server: Apache Vary: Accept-Encoding,Cookie Expires: Thu, 21 Oct 2021 12:55:18 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://www.amrytpharma.com/ Content-Type: text/html; charset=UTF-8 HTTP/2 200 vary: Accept-Encoding,Cookie cache-control: max-age=3, must-revalidate content-type: text/html; charset=UTF-8 date: Thu, 21 Oct 2021 11:55:19 GMT server: Apache |
amrytpharma.com Whois Information
Domain Name: AMRYTPHARMA.COM Registry Domain ID: 1936583848_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.blacknight.com Registrar URL: http://www.blacknight.com Updated Date: 2021-06-08T16:10:02Z Creation Date: 2015-06-08T15:15:43Z Registry Expiry Date: 2023-06-08T15:15:43Z Registrar: Blacknight Internet Solutions Ltd. Registrar IANA ID: 1448 Registrar Abuse Contact Email: abuse@blacknight.com Registrar Abuse Contact Phone: +353599183072 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLACKNIGHT.COM Name Server: NS2.BLACKNIGHT.COM Name Server: NS3.BLACKNIGHT.COM Name Server: NS4.BLACKNIGHT.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T05:37:32Z <<< |